SU-E-T-219: Comprehensive Validation of the Electron Monte Carlo Dose Calculation Algorithm in RayStation Treatment Planning System for An Elekta Linear Accelerator with AgilityTM Treatment Head

2015 ◽  
Vol 42 (6Part15) ◽  
pp. 3382-3382 ◽  
Author(s):  
Yi Wang ◽  
Yang-Kyun Park ◽  
Karen P. Doppke
2010 ◽  
Author(s):  
J. M. Lárraga-Gutiérrez ◽  
O. A. García-Garduño ◽  
O. O. Galván de la Cruz ◽  
M. Hernández-Bojórquez ◽  
P. Ballesteros-Zebadúa ◽  
...  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Naonori Hu ◽  
Hiroki Tanaka ◽  
Ryo Kakino ◽  
Syuushi Yoshikawa ◽  
Mamoru Miyao ◽  
...  

AbstractBoron neutron capture therapy (BNCT) for the treatment of unresectable, locally advanced, and recurrent carcinoma of the head and neck cancer has been approved by the Japanese government for reimbursement under the national health insurance as of June 2020. A new treatment planning system for clinical BNCT has been developed by Sumitomo Heavy Industries, Ltd. (Sumitomo), NeuCure® Dose Engine. To safely implement this system for clinical use, the simulated neutron flux and gamma ray dose rate inside a water phantom was compared against experimental measurements. Furthermore, to validate and verify the new planning system, the dose distribution inside an anthropomorphic head phantom was compared against a BNCT treatment planning system SERA and an in-house developed Monte Carlo dose calculation program. The simulated results closely matched the experimental results, within 5% for the thermal neutron flux and 10% for the gamma ray dose rate. The dose distribution inside the head phantom closely matched with SERA and the in-house developed dose calculation program, within 3% for the tumour and a difference of 0.3 Gyw for the brain.


2015 ◽  
Vol 42 (6Part15) ◽  
pp. 3378-3379 ◽  
Author(s):  
S Ahmad ◽  
A Sarfehnia ◽  
M Paudel ◽  
A Sahgal ◽  
S Hissoiny ◽  
...  

2010 ◽  
Vol 9 (4) ◽  
pp. 209-221 ◽  
Author(s):  
Connor McGarry ◽  
Monica O’Toole ◽  
Vivian Cosgrove

AbstractWhen upgrading treatment planning software, it is important to understand and characterise any changes that may have been made to the system. This includes inverse treatment planning and dose optimisation software used for intensity-modulated radiation therapy (IMRT). A systematic and practical approach to characterising dose optimisation software following upgrades is presented based on a planning study of six IMRT prostate cases using the commercial treatment planning system Oncentra Masterplan (OMP). Upgrades included general changes in the fluence to multileaf collimator (MLC) segmentation algorithm, a change from a two-step to a one-step optimisation method and an upgrade of the dose calculation algorithm. Post upgrade changes in plan parameters such as calculation times, monitor units, segments and target doses were analysed. A 32% reduction in total calculated monitor units was observed following the general software upgrade. A smaller 12% reduction was observed when using the optional one-step optimisation method rather than a two-step process using a classic dose calculation algorithm. An increase in monitor units of approximately 12% was observed when changing to an enhanced dose calculation algorithm. The enhanced dose calculation algorithm accounted for MLC type, leakage and source size unlike the previous classic dose calculation algorithm. Differences in dose to volumes between fluence segmentation and final dose calculation varied between versions. These differences were found to be minimal for the most recent treatment planning system version. Repeatability tests revealed a more effective use of the system. The characterisation of the effects of treatment planning software upgrades allowed a better appreciation of IMRT planning and delivery attributes. Although this work is based on one commercial inverse treatment planning system, it would be easily transferable to other systems as the underlying system principles are the same.


Sign in / Sign up

Export Citation Format

Share Document